X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (63) 63
humans (63) 63
pregnancy (60) 60
chemotherapy (52) 52
obstetrics & gynecology (52) 52
adult (49) 49
oncology (49) 49
tumors (49) 49
disease (43) 43
ema/co (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (39) 39
choriocarcinoma (34) 34
methotrexate (34) 34
etoposide (32) 32
gestational trophoblastic neoplasia (32) 32
actinomycin-d (31) 31
gestational trophoblastic disease - drug therapy (31) 31
etoposide - administration & dosage (30) 30
dactinomycin - administration & dosage (28) 28
index medicus (28) 28
methotrexate - administration & dosage (27) 27
cyclophosphamide (26) 26
management (26) 26
retrospective studies (24) 24
middle aged (22) 22
uterine neoplasms - drug therapy (22) 22
cancer (21) 21
treatment outcome (21) 21
vincristine - administration & dosage (21) 21
cyclophosphamide - administration & dosage (19) 19
gestational trophoblastic disease (19) 19
regimen (19) 19
uterine neoplasms - pathology (19) 19
risk factors (18) 18
vincristine chemotherapy (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
ema-co (17) 17
gestational trophoblastic disease - pathology (17) 17
metastasis (15) 15
prognosis (15) 15
experience (13) 13
methotrexate - therapeutic use (13) 13
salvage therapy (13) 13
risk (12) 12
vincristine (12) 12
young adult (12) 12
adolescent (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
combination chemotherapy (11) 11
follow-up studies (11) 11
neoplasm metastasis (11) 11
dactinomycin (10) 10
drug resistance, neoplasm (10) 10
gestational trophoblastic disease - mortality (10) 10
hysterectomy (10) 10
neoplasm staging (10) 10
survival analysis (10) 10
survival rate (10) 10
therapy (10) 10
dactinomycin - therapeutic use (9) 9
ema-co chemotherapy (9) 9
ema/co etoposide (9) 9
etoposide - therapeutic use (9) 9
trophoblastic neoplasms - drug therapy (9) 9
chorionic gonadotropin - blood (8) 8
etoposide - adverse effects (8) 8
folinic acid (8) 8
gestational trophoblastic disease - therapy (8) 8
remission induction (8) 8
uterine neoplasms - mortality (8) 8
cisplatin - administration & dosage (7) 7
cisplatin/etoposide (7) 7
combined modality therapy (7) 7
cyclophosphamide - therapeutic use (7) 7
dactinomycin - adverse effects (7) 7
ema-co protocol (7) 7
ema/co regimen (7) 7
hematology, oncology and palliative medicine (7) 7
obstetrics and gynecology (7) 7
surgery (7) 7
toxicity (7) 7
vincristine - adverse effects (7) 7
vincristine - therapeutic use (7) 7
antineoplastic agents - therapeutic use (6) 6
brain neoplasms - secondary (6) 6
care and treatment (6) 6
choriocarcinoma - drug therapy (6) 6
cyclophosphamide - adverse effects (6) 6
gestational trophoblastic disease - surgery (6) 6
gestational trophoblastic tumors (6) 6
lung neoplasms - secondary (6) 6
methotrexate - adverse effects (6) 6
trophoblastic neoplasms - pathology (6) 6
uterine neoplasms - surgery (6) 6
choriocarcinoma - secondary (5) 5
chorionic gonadotropin (5) 5
cisplatin (5) 5
combination (5) 5
drug resistance (5) 5
gestational trophoblastic disease - blood (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Gynecology & Obstetrics, ISSN 0020-7292, 12/2018, Volume 143, Issue 3, pp. 388 - 389
Choriocarcinomas are rare malignant trophoblastic tumors. There is a strong need for development of guidelines for therapeutic decision making. 
Choriocarcinoma | EMA‐CO | Non‐gestational choriocarcinoma | Postmenopausal woman | EMA-CO | Non-gestational choriocarcinoma | OBSTETRICS & GYNECOLOGY
Journal Article
Journal Article
European Journal of Gynaecological Oncology, ISSN 0392-2936, 2018, Volume 39, Issue 4, pp. 682 - 684
Placental site trophoblastic tumor (PSTT) is a rare variant of gestational trophoblastic disease. Fertility-sparing therapy for affected women, especially for... 
Indications | EMA/CO | Fertility-sparing treatment | Placental site trophoblastic tumor | Hypervascular | ONCOLOGY | OBSTETRICS & GYNECOLOGY
Journal Article
Gorm, ISSN 1300-4751, 02/2016, Volume 21, Issue 2
OBJECTIVE: In this study, we aimed updating our experience about the treatment success of EMA-CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide,... 
EMA/CO, Gestational trophoblastic neoplasia, Prognostic factors
Journal Article
Bjog : an International Journal of Obstetrics and Gynaecology, ISSN 1470-0328, 2016, Volume 123, Issue 11, pp. 1839 - 1845
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 69, pp. 113920 - 113927
Purpose: To assess the ovarian reserve of patients with gestational trophoblastic neoplasia (GTN) treated with chemotherapy by evaluating serum anti-Mullerian... 
Anti-Müllerian hormone | Chemotherapy | Follicle-stimulating hormone | Gestational trophoblastic neoplasia | follicle-stimulating hormone | VINCRISTINE FAEV | FLOXURIDINE | chemotherapy | CELL BIOLOGY | WOMEN | ETOPOSIDE | OVARIAN RESERVE | anti-Mullerian hormone | gestational trophoblastic neoplasia | EMA/CO | GONADAL-FUNCTION | DACTINOMYCIN
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 2016, Volume 26, Issue 9, pp. 1712 - 1716
Journal Article
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, ISSN 1341-9625, 01/2020, Volume 25, Issue 1, pp. 203 - 209
Objective This study aimed to evaluate the efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide, and actinomycin D (MEA) for patients who... 
Actinomycin D | High-risk gestational trophoblastic neoplasia | CYCLOPHOSPHAMIDE | Etoposide | EMA/CO ETOPOSIDE | VINCRISTINE CHEMOTHERAPY | TUMORS | PREGNANCY | Choriocarcinoma | SALVAGE CHEMOTHERAPY | ONCOLOGY | DISEASE | COMBINATION CHEMOTHERAPY | Methotrexate | DACTINOMYCIN | Index Medicus
Journal Article
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, ISSN 1306-133X, 2019, Volume 29, Issue 3, pp. 168 - 175
This study aims to analyze the clinicopathologic characteristics and treatment outcomes of our patients with gestational trophoblastic neoplasia (GTN) and to... 
CURRENT MANAGEMENT | actinomycin D | PRIMARY THERAPY | CYCLOPHOSPHAMIDE | Trophoblastic Disease | FOLINIC ACID | EMA-CO protocol | Gestational Trophoblastic Neoplasia | METHOTREXATE CHEMOTHERAPY | ETOPOSIDE | ONCOLOGY | DISEASE | VINCRISTINE | BRAIN METASTASES | Methotrexate | ACTINOMYCIN-D
Journal Article
Journal Article
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2012, Volume 13, Issue 1, pp. 387 - 390
A combination of 5-fluorouracil plus actinomycin D (5FU plus Act D) is the regimen that has been commonly administered to Chinese and Japanese gestational... 
5 fluorouracil | Actinomycin D salvage treatment | Gestational trophoblastic neoplasia | 5-FLUOROURACIL | ONCOLOGY | actinomycin D salvage treatment | COMBINATION CHEMOTHERAPY | EMA/CO | TUMORS
Journal Article
BMC CANCER, ISSN 1471-2407, 08/2019, Volume 19, Issue 1, pp. 770 - 9
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.